4-0_header

Infectious Disease and Vaccines

WCCT Update to Coronavirus / COVID-19

***If you are interested in conducting a clinical trial for a vaccine or anti-viral targeting COVID-19, please reach out to us via our website here***

Infectious Diseases and Vaccines Clinical Trial Services

A breadth of experience in both therapeutic and preventative clinical development.

Since our founding in 1998, WCCT has conducted over 80 clinical trials in the area of Infections and Infectious Disease. Supported by expert scientific, medical, regulatory, and clinical staff, the WCCT clinical pharmacology unit supports the streamlined clinical development of new vaccines, anti-viral therapies, delivery systems, and antimicrobial agents in a timely, cost-effective manner. Partner with a leader that has a track record in infectious diseases and vaccines clinical trial services.

WCCT has infectious disease experience in the following indications:
  • Bacterial infection
  • Common cold
  • MERS
  • HBV
  • HCV
  • HIV
  • RSV
  • Complicated skin infections
  • Fungal infections
  • Herpes Zoster
  • Influenza

WCCT Vaccine Clinical Trial Services - Infectious Disease Experience

Vaccines

Within this broad therapeutic area, WCCT has also developed a specific expertise in the development of new vaccines for various indications. Our vaccines clinical trial services are extensive and comprehensive. Since 2008, we have conducted over 20 vaccine trials for the following conditions:

  • Seasonal influenza
  • Pandemic influenza
  • Norovirus
  • Hepatitis B
  • HPV
  • HSV

Vaccines Clinical Trial Services Experience

With a comprehensive understanding of FDA regulations and requirements for vaccine approval, and access to a large database of clinical research volunteers, we are uniquely positioned to streamline the clinical development of new vaccines and delivery systems.

In-House Vaccine Development Capabilities:
  • Robust database of 55,000 clinical research volunteers ready to participate in vaccine trials
  • Three distinct wards within our 180-bed clinical pharmacology unit which can be used to separate volunteers and are customizable to the needs of the protocol
  • CAP Accredited and CLIA Certified Safety Reference Laboratory with the following features relevant to vaccine testing:
    • Respiratory Panel Testing through the BioFire FilmArray Multiplex PCR System to evaluate the presence of an infection in the respiratory tract of immuno-compromised patients
      • Staff trained to collect samples using nasopharyngeal swabs
    • Ability to isolate Peripheral Blood Mononuclear Cells (PBMCs) through multiple collection methods dependent upon Sponsor goals—PBMCs are a means to evaluate the immune response of cells under various conditions
    • Biosafety Laboratory Level 2 facility with limited badge access, several biosafety cabinets, BioHazard-trained staff, cleaning protocols, and procedures in-place for containment issues
    • Long-term sample storage. Planned Biorepository accreditation in May 2020: Accreditation represents compliance with:
      • GCLP guidelines for sample processing and storage
      • FDA, CAP, and the Center for Medicaid Services for safety monitoring, sample collection, source document creation, data management, biostatistical analysis, and more

Early Clinical Development

Submit RFI/RFP

Tell us about your study to receive a customized proposal.

Start typing and press Enter to search